REFINING THE ROLE OF BETA-BLOCKERS INCARDIOVASCULAR MEDICINE

Saint Luke’s Mid America Heart Institute, University of Missouri, Mount Sinai Fuster Heart Hospital, Ziekenhuis Oost-Limburg, UHasselt, Cooper Medical School of Rowan University, Cleveland Clinic Foundation

Beta-blockers have historically been a cornerstone of treatment in cardiovascular medicine, but recent randomized trials and population studies have prompted a reevaluation of their use. This review synthesizes contemporary evidence regarding beta-blocker efficacy and safety, particularly in conditions such as heart failure and atrial fibrillation. The authors discuss the need for updated clinical guidelines that reflect these new insights and address the challenges of therapeutic inertia in clinical practice.